These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 32574650

  • 21. Chronic cannabidiol (CBD) administration induces anticonvulsant and antiepileptogenic effects in a genetic model of epilepsy.
    Lazarini-Lopes W, Do Val-da Silva RA, da Silva-Júnior RMP, Silva-Cardoso GK, Leite-Panissi CRA, Leite JP, Garcia-Cairasco N.
    Epilepsy Behav; 2021 Jun; 119():107962. PubMed ID: 33887676
    [Abstract] [Full Text] [Related]

  • 22. Prophylactic Administration of Cannabidiol Reduces Microglial Inflammatory Response to Kainate-Induced Seizures and Neurogenesis.
    Victor TR, Hage Z, Tsirka SE.
    Neuroscience; 2022 Sep 15; 500():1-11. PubMed ID: 35700815
    [Abstract] [Full Text] [Related]

  • 23. Assessing the role of serotonergic receptors in cannabidiol's anticonvulsant efficacy.
    Pelz MC, Schoolcraft KD, Larson C, Spring MG, López HH.
    Epilepsy Behav; 2017 Aug 15; 73():111-118. PubMed ID: 28624721
    [Abstract] [Full Text] [Related]

  • 24. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC, Patra PH, Whalley BJ.
    Epilepsy Behav; 2017 May 15; 70(Pt B):319-327. PubMed ID: 28190698
    [Abstract] [Full Text] [Related]

  • 25. Cannabidiol--antiepileptic drug comparisons and interactions in experimentally induced seizures in rats.
    Consroe P, Wolkin A.
    J Pharmacol Exp Ther; 1977 Apr 15; 201(1):26-32. PubMed ID: 850145
    [Abstract] [Full Text] [Related]

  • 26. The Anticonvulsant and Neuroprotective Effects of Oxysophocarpine on Pilocarpine-Induced Convulsions in Adult Male Mice.
    Liu G, Wang J, Deng XH, Ma PS, Li FM, Peng XD, Niu Y, Sun T, Li YX, Yu JQ.
    Cell Mol Neurobiol; 2017 Mar 15; 37(2):339-349. PubMed ID: 27481234
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP).
    Klein BD, Jacobson CA, Metcalf CS, Smith MD, Wilcox KS, Hampson AJ, Kehne JH.
    Neurochem Res; 2017 Jul 15; 42(7):1939-1948. PubMed ID: 28478594
    [Abstract] [Full Text] [Related]

  • 28. Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis.
    Giacoppo S, Pollastro F, Grassi G, Bramanti P, Mazzon E.
    Fitoterapia; 2017 Jan 15; 116():77-84. PubMed ID: 27890794
    [Abstract] [Full Text] [Related]

  • 29. The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system.
    Campos AC, Ortega Z, Palazuelos J, Fogaça MV, Aguiar DC, Díaz-Alonso J, Ortega-Gutiérrez S, Vázquez-Villa H, Moreira FA, Guzmán M, Galve-Roperh I, Guimarães FS.
    Int J Neuropsychopharmacol; 2013 Jul 15; 16(6):1407-19. PubMed ID: 23298518
    [Abstract] [Full Text] [Related]

  • 30. The complexity of pharmacology of cannabidiol (CBD) and its implications in the treatment of brain disorders.
    Elsaid S, Le Foll B.
    Neuropsychopharmacology; 2020 Jan 15; 45(1):229-230. PubMed ID: 31511618
    [No Abstract] [Full Text] [Related]

  • 31. Preclinical efficacy of cannabidiol for the treatment of early-life seizures.
    Witherspoon E, Quinlan S, Forcelli PA.
    Pharmacol Rep; 2022 Oct 15; 74(5):1092-1098. PubMed ID: 36220975
    [Abstract] [Full Text] [Related]

  • 32. Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.
    Golub V, Reddy DS.
    Adv Exp Med Biol; 2021 Oct 15; 1264():93-110. PubMed ID: 33332006
    [Abstract] [Full Text] [Related]

  • 33. Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor.
    Rodríguez-Muñoz M, Onetti Y, Cortés-Montero E, Garzón J, Sánchez-Blázquez P.
    Mol Brain; 2018 Sep 17; 11(1):51. PubMed ID: 30223868
    [Abstract] [Full Text] [Related]

  • 34. Anticonvulsant and antiepileptogenic effects of system xc- inactivation in chronic epilepsy models.
    Leclercq K, Liefferinge JV, Albertini G, Neveux M, Dardenne S, Mairet-Coello G, Vandenplas C, Deprez T, Chong SA, Foerch P, Bentea E, Sato H, Maher P, Massie A, Smolders I, Kaminski RM.
    Epilepsia; 2019 Jul 17; 60(7):1412-1423. PubMed ID: 31179549
    [Abstract] [Full Text] [Related]

  • 35. The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors.
    Castillo A, Tolón MR, Fernández-Ruiz J, Romero J, Martinez-Orgado J.
    Neurobiol Dis; 2010 Feb 17; 37(2):434-40. PubMed ID: 19900555
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of the FDA-approved cannabidiol on the development and persistence of temporal lobe epilepsy and complex focal onset seizures.
    Reddy DS, Mbilinyi RH, Ramakrishnan S.
    Exp Neurol; 2023 Jan 17; 359():114240. PubMed ID: 36216124
    [Abstract] [Full Text] [Related]

  • 37. PI3Kγ/AKT Signaling in High Molecular Weight Hyaluronan (HMWH)-Induced Anti-Hyperalgesia and Reversal of Nociceptor Sensitization.
    Bonet IJM, Khomula EV, Araldi D, Green PG, Levine JD.
    J Neurosci; 2021 Oct 06; 41(40):8414-8426. PubMed ID: 34417329
    [Abstract] [Full Text] [Related]

  • 38. Cannabis and Endocannabinoid Signaling in Epilepsy.
    Katona I.
    Handb Exp Pharmacol; 2015 Oct 06; 231():285-316. PubMed ID: 26408165
    [Abstract] [Full Text] [Related]

  • 39. Synthetic, non-intoxicating 8,9-dihydrocannabidiol for the mitigation of seizures.
    Mascal M, Hafezi N, Wang D, Hu Y, Serra G, Dallas ML, Spencer JPE.
    Sci Rep; 2019 May 23; 9(1):7778. PubMed ID: 31123271
    [Abstract] [Full Text] [Related]

  • 40. Effects of chronic cannabidiol in a mouse model of naturally occurring neuroinflammation, neurodegeneration, and spontaneous seizures.
    Dearborn JT, Nelvagal HR, Rensing NR, Takahashi K, Hughes SM, Wishart TM, Cooper JD, Wong M, Sands MS.
    Sci Rep; 2022 Jul 04; 12(1):11286. PubMed ID: 35789177
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.